Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMAN C1-ESTERASE INHIBITOR vs LANADELUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HUMAN C1-ESTERASE INHIBITOR vs LANADELUMAB: Safety Overview

Metric HUMAN C1-ESTERASE INHIBITOR LANADELUMAB
Total FAERS Reports 14,344 2,058
Deaths Reported 1,403 109
Death Rate 9.8% 5.3%
Hospitalizations 3,966 1,007
Average Patient Age 42.7 yrs 47.3 yrs
% Female Patients 79.1% 75.7%
Manufacturer Takeda Pharmaceuticals America, Inc. Takeda Pharmaceuticals America, Inc.
Route N/A SUBCUTANEOUS